Recent articles

In the words of Colin Dayan, M.D., Ph.D., professor of clinical diabetes and metabolism at Cardiff University: “Type 1 diabetes is almost the only major autoimmune disease now that does not have a licensed immunotherapy.” And he’s going to change that.

“I’d like to share a personal dream. A dream that one day children will be told, ‘like Polio, there once was a disease called diabetes. With your help, that dream may become a reality.” – Maurice Hertzfeld, testifying at the 1975 National Commission on Diabetes Rob Hertzfeld was 14 years old when he was diagnosed […]

“Even now I can hear that ghostly whisper from 48 years ago. The doctor’s voice, ‘Mrs. Greenspon, your son has diabetes.'” – Roz Greenspon, Charlotte, NC He was talking about Keith, 8 years old, the oldest of our 3 children. “But,” the doctor added as he exited the room, “Don’t worry. He’ll take insulin – […]

Accurate control of blood sugar for people with type 1 diabetes (T1D) was not easy in the 1970s. At the time, the degree of diabetes control relied on patient history, urinary sugar and blood-sugar measurement at the time of the doctor’s visit. There was nothing that could tell you what your blood-sugar levels were for […]

The Food and Drug Administration (FDA) approved the Medtronic MiniMed 770G artificial pancreas system for use by children aged 2 to 6 with type 1 diabetes (T1D). It is the first marketed device that can automatically adjust insulin delivery based on continuous glucose monitoring (CGM) values for children aged 2-6 years.

A clinical trial at four pediatric diabetes centers in the United States has found that a new artificial pancreas system—which automatically monitors and regulates blood-sugar levels—is safe and effective in children as young as age six with type 1 diabetes (T1D): Tandem’s t:slim X2™ insulin pump with Control-IQ™ technology. The algorithm in the Control-IQ technology […]

Social distancing is key in preventing the spread of COVID, but what happens when school starts? Members of the Type 1 Diabetes Community from Spanish-speaking families share their perspectives.

While genetics play a major role in the development of type 1 diabetes (T1D), mounting evidence supports the strong influence of the intestinal environment—called the microbiome—in this disease. Nevertheless, few “microbiome-based” strategies have been tested in clinical trials. Recently, Graciela Lorca, Ph.D., professor of microbiology at the University of Florida, found that one bacterial strain—a […]

Press releases

Read the latest press releases and statements from Breakthrough T1D.

Get the latest in T1D news updates

Sign up for Insider News to receive breaking news updates from Breakthrough T1D.

  • This field is for validation purposes and should be left unchanged.